Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) — Cash Flow Quality Index
Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Cash Flow Quality Index of 0.11x as of December 2023. Operating cash flow of CN¥26.95 Million is below net income of CN¥243.07 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 301089 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Cash Flow Quality Index (2019–2023)
Historical Cash Flow Quality Index for Xinxiang Tuoxin Pharmaceutical Co.Ltd. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Xinxiang Tuoxin Pharmaceutical Co.Ltd. generate cash.
Annual Cash Flow Quality Index for Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2023)
Year-by-year earnings quality comparison for Xinxiang Tuoxin Pharmaceutical Co.Ltd..
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.11x | CN¥26.95 Million | CN¥243.07 Million | ▼ -88.2% |
| 2022 | 0.94x | CN¥268.85 Million | CN¥286.54 Million | ▲ +5.9% |
| 2021 | 0.89x | CN¥58.19 Million | CN¥65.71 Million | ▼ -16.8% |
| 2020 | 1.06x | CN¥120.00 Million | CN¥112.80 Million | ▼ -24.6% |
| 2019 | 1.41x | CN¥86.38 Million | CN¥61.25 Million | — |